| Literature DB >> 28808411 |
Jong Woong Park1, Han-Soo Kim1, Cheol Lee2, Hye Jin Yoo3, Ji Yeon Yun1, Ilkyu Han1.
Abstract
Soft tissue sarcoma (STS) with an infiltrative histologic growth pattern, when compared to STS with an expansile pattern, may pose difficulties in local control. Preoperative assessment of the presence of infiltrative histologic growth pattern would be helpful in deciding treatment strategies. A review of 144 patients who underwent surgery for extremity STS was performed. Microscopically, the histologic growth pattern was defined as infiltrative if the penetration of the tumor cells into the surrounding tissue was observed. Possible clinicopathologic factors that might be associated with infiltrative histologic growth pattern were investigated with regard to patient demographics, tumor characteristics, and MRI findings. Of the 144 tumors, 71 (49%) showed infiltrative histologic growth pattern. On multivariate analysis, histological subtypes other than liposarcoma (OR = 4.57, p = 0.02) and infiltrative border on MRI (OR = 2.48, p = 0.01) were independent factors associated with infiltrative histologic growth pattern. Predictive index based on these two factors showed a significant improved accuracy (ROC-AUC = 0.647) for predicting infiltrative histologic growth pattern compared to either factor alone. Our data suggests that liposarcoma histology and tumor border on MRI can predict histologic growth pattern in extremity STS.Entities:
Year: 2017 PMID: 28808411 PMCID: PMC5541793 DOI: 10.1155/2017/5419394
Source DB: PubMed Journal: Sarcoma ISSN: 1357-714X
Figure 1Representative sections of histologic growth pattern. Photomicrograph and MRI ((a) gross, (b) gadolinium-enhanced T1-weighted sequences with fat suppression, and (c) H&E staining, magnification ×1) of the histological specimen of an subcutaneous synovial sarcoma with expansile growth pattern. Photomicrograph ((d) gross, (e) gadolinium-enhanced T1-weighted sequences with fat suppression, and (f) H&E staining, magnification ×1) of the histological specimen of a subcutaneous undifferentiated pleomorphic sarcoma with an infiltrative growth pattern.
Preoperative characteristics.
| Patient characteristics | |
|---|---|
| Mean age (yrs, SDa) | 50.0 (19.7) |
| Gender ( | |
| Female | 63 (44) |
| Male | 81 (56) |
| Presentation status ( | |
| Fresh | 101 (70) |
| Recurred | 22 (15) |
| Unplanned excision | 21 (15) |
| Radiation therapy ( | |
| Preoperative | 1 (1) |
| Postoperative | 82 (57) |
| Not done | 61 (42) |
| Dose of radiation therapy (Gy, range) | 60 (50–65) |
| Chemotherapy ( | |
| Preoperative | 3 (2) |
| Postoperative | 18 (13) |
| Pre- and postoperative | 7 (5) |
| Not done | 116 (80) |
|
| |
| Tumor characteristics | |
|
| |
| Size (cm, SD) | 7.7 (6.4) |
| Depth ( | |
| Superficial | 21 (15) |
| Deep | 123 (85) |
| Compartmental status ( | |
| Intracompartmental | 91 (63) |
| Extracompartmental | 53 (37) |
| FNCLCC grade ( | |
| 1 | 23 (16) |
| 2 | 54 (38) |
| 3 | 67 (46) |
| Histologic type ( | |
| UPSb | 26 (18) |
| Synovial sarcoma | 23 (16) |
| Myxofibrosarcoma | 22 (15) |
| Liposarcoma | 17 (12) |
| Leiomyosarcoma | 14 (10) |
| Others | 42 (29) |
|
| |
| MRI characteristics | |
|
| |
| Peritumoral edema ( | |
| Absent | 105 (73) |
| Present | 39 (27) |
| Tumor border on MRI ( | |
| Pushing | 57 (40) |
| Infiltrative | 87 (60) |
aSD, standard deviation; bUPS; undifferentiated pleomorphic sarcoma.
Figure 2Representative images of different tumor borders on MRI. (a) T1 enhanced MRI of an intramuscular synovial sarcoma with pushing border on MRI. (b) T1 enhanced MRI of an intramuscular undifferentiated pleomorphic sarcoma with infiltrative border on MRI with the tail sign. (c) T1 enhanced MRI of a leiomyosarcoma with infiltrative border on MRI without the tail sign.
Comparison of preoperative characteristics by histological growth pattern.
| Expansile | Infiltrative |
| |
|---|---|---|---|
| Mean age (years, SDa) | 48 (20) | 52 (20) | 0.14 |
| Gender ( | 0.52 | ||
| Female | 30 | 33 | |
| Male | 43 | 38 | |
| Preoperative radiation therapy ( | 0.49 | ||
| Done | 0 | 1 | |
| Not done | 73 | 70 | |
| Preoperative chemotherapy ( | 0.53 | ||
| Done | 4 | 6 | |
| Not done | 69 | 65 | |
| Depth ( | 0.03 | ||
| Superficial | 6 | 15 | |
| Deep | 67 | 56 | |
| Size (cm, SD) | 7.7 (5.1) | 7.6 (7.5) | 0.91 |
| Compartmental status ( | 0.52 | ||
| Intracompartmental | 48 | 43 | |
| Extracompartmental | 25 | 28 | |
| Presentation status ( | 0.20 | ||
| Fresh | 56 | 45 | |
| Recurred | 8 | 14 | |
| Unplanned excision | 9 | 12 | |
| Peritumoral edema ( | 0.65 | ||
| Absent | 52 | 53 | |
| Present | 21 | 18 | |
| Tumor border on MRI ( | 0.01 | ||
| Pushing | 37 | 20 | |
| Infiltrative | 36 | 51 | |
| FNCLCC grade ( | 0.83 | ||
| 1 | 13 | 10 | |
| 2 | 27 | 27 | |
| 3 | 33 | 34 | |
| Surgical margin ( | 0.32 | ||
| Wide | 66 | 59 | |
| Marginal | 7 | 11 | |
| Intralesional | 0 | 1 | |
| Pathologic margin ( | 0.35 | ||
| Negative | 68 | 63 | |
| Positive | 5 | 8 | |
| Local recurrence ( | 0.37 | ||
| No | 59 | 53 | |
| Yes | 14 | 18 | |
| Metastasis ( | 0.56 | ||
| No | 46 | 48 | |
| Yes | 27 | 23 |
aSD, standard deviation.
Preoperative factors associated with histological growth pattern.
| Factors | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| ORa | 95% CIb |
| OR | 95% CI |
| |
| Age | 1.01 | 1.00–1.03 | 0.14 | |||
| Gender | 0.80 | |||||
| Female | 1.00 | |||||
| Male | 0.80 | 0.41–1.55 | ||||
| Preoperative radiation therapy | 1.00 | |||||
| Done | 1.00 | |||||
| Not done | 1.00 | |||||
| Preoperative chemotherapy | 0.49 | |||||
| Done | 1.59 | 0.43–5.90 | ||||
| Not done | 1.00 | |||||
| Depth | 0.03c | |||||
| Superficial | 3.00 | 1.09–8.22 | ||||
| Deep | 1.00 | |||||
| Size | 1.00 | 0.95–1.05 | 0.91 | |||
| Compartmental status | 0.51 | |||||
| Intracompartmental | 1.00 | |||||
| Extracompartmental | 1.25 | 0.63–2.46 | ||||
| Previous treatment | 0.20 | |||||
| Fresh | 1.00 | |||||
| Recurred | 2.18 | 0.84–5.65 | ||||
| Unplanned excision | 1.66 | 0.64–4.29 | ||||
| Peritumoral edema | 0.65 | |||||
| Absent | 1.00 | |||||
| Present | 0.84 | 0.40–1.76 | ||||
| Tumor border on MRI | 0.01c | 0.01c | ||||
| Pushing | 1.00 | 1.00 | ||||
| Infiltrative | 2.62 | 1.31–5.23 | 2.48 | 1.21–5.08 | ||
| FNCLCC grade | 0.83 | |||||
| 1 | 1.00 | |||||
| 2 | 1.30 | 0.49–3.47 | ||||
| 3 | 1.34 | 0.52–3.48 | ||||
| Liposarcoma | 0.01c | 0.02c | ||||
| Liposarcoma | 1.00 | 1.00 | ||||
| Others | 5.38 | 1.47–19.63 | 4.57 | 1.22–17.05 | ||
aOR, odds ratio; bCI, confidence interval; cstatistically significant.
Figure 3Pairwise AUC comparison of the predictive index and the tumor border on MRI alone or histological subtype other than liposarcoma alone in predicting infiltrative histologic growth pattern. (a) Pairwise area under the receiver-operating curve (AUC) comparison of the predictive index and the tumor border on MRI alone in predicting infiltrative histological growth pattern. (b) Pairwise area under the receiver-operating curve (AUC) comparison of the predictive index and histological subtype other than liposarcoma alone in predicting infiltrative histological growth pattern. AUC, area under the curve. The dashed line in both graphs represented random guess to predict (AUC = 0.500).